Probing the multi-physical probabilistic dynamics of a novel functional class of hybrid composite shells

2020 ◽  
pp. 113294
Author(s):  
Vaishali ◽  
T. Mukhopadhyay ◽  
R.R. Kumar ◽  
S. Dey
Keyword(s):  
Hybrid Composite ◽  
Functional Class ◽  
Composite Shells

Thermal Buckling and Flutter Behavior of Shape Memory Alloy Hybrid Composite Shells

2009 ◽  
Vol 46 (3) ◽  
pp. 895-902 ◽  
Author(s):  
Hesham Hamed Ibrahim ◽  
Hong Hee Yoo ◽  
Kwan-Soo Lee
Keyword(s):  
Shape Memory Alloy ◽  
Shape Memory ◽  
Hybrid Composite ◽  
Thermal Buckling ◽  
Composite Shells

118 NT-proBNP values and Weber functional class classification in patients with chronic heart failure

2007 ◽  
Vol 6 (1) ◽  
pp. 29-29
Author(s):  
R FERNANDES ◽  
R SOARES ◽  
J FELICIANO ◽  
J SERRA ◽  
A MAMEDE ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Functional Class

235 E/Vp is related to the functional class in a population with dyspnea

2006 ◽  
Vol 5 (1) ◽  
pp. 47-48
Author(s):  
M RIVERAOTERO ◽  
L MAINAR ◽  
M SANCHOTELLO ◽  
E ROSELLO ◽  
V CLIMENT ◽  
...  
Keyword(s):  
Functional Class

Right ventricular dysfunction functional class in diastolic and systolic left-sided heart failure

2008 ◽  
Vol 7 ◽  
pp. 134-134
Author(s):  
J OREATEJEDA ◽  
L CASTILLOMARTINEZ ◽  
R SILVATINOCO ◽  
V REBOLLARGONZALEZ ◽  
E COLINRAMIREZ ◽  
...  
Keyword(s):  
Heart Failure ◽  
Right Ventricular ◽  
Ventricular Dysfunction ◽  
Right Ventricular Dysfunction ◽  
Functional Class

Pulmonary Vascular Versus Right Ventricular Function Changes During Targeted Therapies of Pulmonary Hypertension – An Argument for Upfront Combination Therapy?

2012 ◽  
Vol 8 (3) ◽  
pp. 209
Author(s):  
Wouter Jacobs ◽  
Anton Vonk-Noordegraaf ◽  
◽  
Keyword(s):  
Combination Therapy ◽  
Right Ventricle ◽  
Right Ventricular ◽  
Pulmonary Vascular Resistance ◽  
Vascular Resistance ◽  
Meta Analysis ◽  
Right Heart Failure ◽  
Functional Class ◽  
Pulmonary Vasculature ◽  
The Right

Pulmonary arterial hypertension is a progressive disease of the pulmonary vasculature, ultimately leading to right heart failure and death. Current treatment is aimed at targeting three different pathways: the prostacyclin, endothelin and nitric oxide pathways. These therapies improve functional class, increase exercise capacity and improve haemodynamics. In addition, data from a meta-analysis provide compelling evidence of improved survival. Despite these treatments, the outcome is still grim and the cause of death is inevitable – right ventricular failure. One explanation for this paradox of haemodynamic benefit and still worse outcome is that the right ventricle does not benefit from a modest reduction in pulmonary vascular resistance. This article describes the physiological concepts that might underlie this paradox. Based on these concepts, we argue that not only a significant reduction in pulmonary vascular resistance, but also a significant reduction in pulmonary artery pressure is required to save the right ventricle. Haemodynamic data from clinical trials hold the promise that these haemodynamic requirements might be met if upfront combination therapy is used.

Sign in / Sign up

Export Citation Format

Share Document